1. Skip to content

Mesothelioma Cancer Resources Blog

  • ADI-PEG 20 Shows Promise in Inhibiting Mesothelioma Cancer Cell Growth

    Polaris Group has announced the start of a global phase 3 clinical trial to test the efficacy of ADI-PEG 20 in the treatment of mesothelioma, melanoma and other cancers.  The drug, pegylated arginine deiminase (ADI-PEG 20), has been found to inhibit cancer cell growth in certain cancers.  Initial tests with mesothelioma have been promising. Mesothelioma …

    Label: Treatment News

    Posted on Friday, Jul 16, 2010
  • New MesotheliomaHelp Website Unveiled

    MesotheliomaHelp.net, a comprehensive website dedicated to providing current and accurate information about mesothelioma, has a new look. The newly designed site features improved navigation with easier to find answers to your questions about mesothelioma. Mesothelioma is a rare, aggressive cancer primarily caused by exposure to airborne asbestos fibers. Symptoms of mesothelioma may not appear until …

    Label: Mesothelioma

    Posted on Thursday, Jul 8, 2010